Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Abstract Text:

Veronica C Ardi,Tatyana A Kupriyanova,Elena I Deryugina,James P Quigley,Veronica C Ardi,Tatyana A Kupriyanova,Elena I Deryugina,James P Quigley,

Several lines of evidence have implicated matrix metalloproteinase 9 (MMP-9) as a protease inducing an angiogenic switch critical for tumor progression. Among MMP-9-expressing cell types, including cancer cells and tumor-associated leukocytes, inflammatory neutrophils appear to provide an important source of MMP-9 for tumor angiogenesis. However, delivery of MMP-9 by neutrophils has not been mechanistically linked to its catalytic activity at the angiogenic site. By using a modified angiogenic model, allowing for a direct analysis of exogenously added cells and their products in collagen onplants grafted on the chorioallantoic membrane of the chicken embryo, we demonstrate that intact human neutrophils and their granule contents are highly angiogenic. Furthermore, purified neutrophil MMP-9, isolated from the released granules as a zymogen (proMMP-9), constitutes a distinctly potent proangiogenic moiety inducing angiogenesis at subnanogram levels. The angiogenic response induced by neutrophil proMMP-9 required activation of the tissue inhibitor of metalloproteinases (TIMP)-free zymogen and the catalytic activity of the activated enzyme. That the high angiogenic potency of neutrophil proMMP-9 is associated with its unique TIMP-free status was confirmed when a generated and purified stoichiometric complex of neutrophil proMMP-9 with TIMP-1 failed to induce angiogenesis. Recombinant human proMMP-9, operationally free of TIMP-1, also induced angiogenesis at subnanomolar levels, but lost its proangiogenic potential when stoichiometrically complexed with TIMP-1. Similar proMMP-9/TIMP-1 complexes, but naturally produced by human monocytic U937 cells and HT-1080 fibrosarcoma cells, did not stimulate angiogenesis. These findings provide biochemical evidence that infiltrating neutrophils, in contrast to other cell types, deliver a potent proangiogenic moiety, i.e., the unencumbered TIMP-free MMP-9.

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Publishing Authors By Initials

VC Ardi,TA Kupriyanova,EI Deryugina,JP Quigley,VC Ardi,TA Kupriyanova,EI Deryugina,JP Quigley,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Proceedings of the National Academy of Sciences of

VOLUME: 104

Page Numbers: 20262-7

Journal Abbreviation: Proc. Natl. Acad. Sci. U.S.A.

ISSN: 1091-6490

DAY: 11

MONTH: 12

YEAR: 2007

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7505876

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.

AFFILIATION: Department of Cell Biology, The Scripps Research Institute, 10550 Torrey Pines Road, La Jolla, CA 92037, USA.

Country: United States

AGENCY: United States NHLBI

GRANT: T32 HL07195

ACRONYM: HL

MEDLINETA: Proc Natl Acad Sci U S A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis Related Publications

• A 10-year study of cesarean section in Rochester and Monroe County, 1937 to 1946.
• A 51-year-old with irritable bowel syndrome: test or treat for bacterial overgrowth?
• A NICE fallacy.
• Aspiration of the elbow joint in the treatment of fractures of the head of the radius.
• Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication.
• Bacteria: a new player in gastrointestinal motility disorders-infections, bacterial overgrowth, and probiotics.
• Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes.
• Clinical practice algorithm: Medication management to reduce fall risk in the elderly-Part 1.
• Clinical practice algorithms: Medication management to reduce fall risk in the elderly-Part 2, summary algorithm.
• Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.
• Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.
• Experiences with anticoagulant therapy.
• Exploratory behavior in mice selectively bred for developmental differences in aggressive behavior.
• Factors affecting the decision to pursue glaucoma fellowship training.
• Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications.
• Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
• Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
• Humans have always tried to improve their condition.
• Impact of pregnancy and parturition on the anal sphincters and pelvic floor.
• Inverted and deleted chromosome 16 with deletion of 3'CBFB identified by fluorescence in situ hybridization.
• Long-term survival enhanced by cordectomy in a patient with a spinal glioblastoma multiforme and paraplegia. Case report.
• Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice.
• Non-human primates: the appropriate subjects of biomedical research?
• Probiotics in irritable bowel syndrome: an immunomodulatory strategy?
• Probiotics in the management of colonic disorders.
• Property and the body: applying Honore.
• Risk factors and open-angle glaucoma: classification and application.
• The 'con' case. The Rome process and functional gastrointestinal disorders: the barbarians are at the gate!
• The theory of planned behavior and binge drinking: assessing the impact of binge drinker prototypes.
• Understanding the reporting practices of CAHPS sponsors.